Articles |
From INSERM U-390, Physiopathologie Cardiovasculaire, Montpellier, France.
Correspondence to Dr Guy Vassort, INSERM U-390, Physiopathologie Cardiovasculaire, CHU Arnaud de Villeneuve, F-34295 Montpellier Cedex 05, France. E-mail vassort{at}u390.montp.inserm.fr
| Abstract |
|---|
|
|
|---|
Key Words: ATP-sensitive K+ channel purinergic stimulation G protein adenylyl cyclase ATP depletion
| Introduction |
|---|
|
|
|---|
Modulation of the cardiac KATP channel has been the basis
of numerous pharmacological studies, since these channels, abundant in
the sarcolemma of mammalian cardiomyocytes, including human ventricular
cells,7 may link directly the metabolic status of a cell
to its membrane potential.1 Sulfonylureas are the most
selective inhibitors of these channels, and they are used for long-term
treatment of noninsulin-dependent type II diabetes, whereas numerous
synthetic KATP channel openers are currently suggested for
their cardioprotective effects.4 Endogenous ligands may
also regulate KATP channels. Adenosine and acetylcholine
are expected stimulators of cardiac KATP channels, since it
has been reported that the activation of A1-adenosine and
muscarinic receptors in the presence of GTP at the inner side of
sarcolemma fragments excised from neonatal rat ventricular
cells8 and adult guinea pig atrial9 and
ventricular10 myocytes induces an increase in
KATP channel activity at submillimolar ATPi.
According to these authors, such an activation occurs via a direct
membrane-delimited pathway that involves a PTX-sensitive G protein.
However, G
i-1,
G
i-2, or G
o proteinmediated
decrease in ATPi sensitivity of KATP channel, a
mechanism attributed to this direct pathway,11 is not
sufficient by itself to activate the KATP channel at
physiological (millimolar) ATPi.12
Alternatively, second messengerdependent pathways could be
implicated. A stimulatory effect of acetylcholine on IK-ATP
in cat atrial cells has been reported to be mediated via PKC, ie, an
indirect nonmembrane-delimited signaling pathway.13 An
indirect cAMP-dependent pathway has been proposed to account for the
ß-adrenergicinduced increase of the pinacidil-activated
IK-ATP in canine ventricular myocytes.14 More
recently, a stimulatory effect of isopro-terenol on
IK-ATP appearing during ATPi depletion in
cat ventricular myocytes was shown to be mediated by adenylyl
cyclase activation without involvement of PKA.15
Although adenosine is the most considered purinergic agonist released during ischemia and other pathophysiological conditions, the ATP concentration in the extracellular space might also transiently increase.16 17 ATPe affects heart function through multiple mechanisms, including modulation of different ion channels.18 ATPe was first shown to activate a nonselective cationic conductance19 20 and to increase Ca2+ current.21 ATPe also activates a Cl- current22 and is reported to stimulate inwardly rectifying, G proteingated, delayed rectifier as well as muscarinic receptoractivated K+ channels in atrial cells.23 24 25
In the present study, the effects of ATPe were examined on IK-ATP in isolated rat ventricular myocytes. Under whole-cell patch-clamp conditions, ATPe, in the presence of an adenosine receptor antagonist, enhanced IK-ATP during its slow development in cells dialyzed with a low ATPcontaining solution. This ATPe-induced modulation of IK-ATP implied that a cholera toxinsensitive G protein might be involved. Experiments in inside-out patch configuration demonstrated that the addition of GTP to the inner side of membrane fragments bathed in the low ATPcontaining "intracellular" solution increases the Po of KATP channels independent of the presence of ATPe at the outer side of membrane. IK-ATP enhancement was prevented by adenylyl cyclase inhibition; however, PKA activation was not necessary to mediate this effect of ATPe. Thus, it is proposed that ATPe-induced enhancement of IK-ATP in rat ventricular myocytes is caused by subsarcolemmal ATP depletion subsequent to adenylyl cyclase activation.
| Materials and Methods |
|---|
|
|
|---|
103 cells/mL) for 8 to
10 hours at 37°C. Thirty microliters of cell suspension was dropped
in a specially designed 0.7-mL perfused bath chamber mounted on a
Diaphot 200 inverted Nikon microscope 10 minutes before the
electrophysiological experiment, in which only a clearly striated
myocyte with smooth surface was used.
Solutions and Reagents
The buffer solution for cell preparation had the following
composition (mmol/L): NaCl 123, KCl 5.4, NaHCO3 5,
NaH2PO4 2, MgCl2 1.6, glucose 10,
taurine 20, and HEPES 20 (pH 7.2 at 23°C adjusted with 1 mol/L NaOH).
The standard external control solution ("extracellular" bath
solution in whole-cell and outside-out configuration or pipette
solution in cell-attached and inside-out configuration of the
patch-clamp technique) contained (mmol/L) NaCl 140, KCl 5,
MgCl2 1, CaCl2 1, and HEPES 10 (pH 7.4 adjusted
with 1 mol/L NaOH). In some experiments, K+-rich external
solution containing (mmol/L) KCl 145, MgCl2 1,
CaCl2 1, and HEPES 10 (pH 7.4 adjusted with 1 mol/L KOH)
was used. DPCPX (10 µmol/L), a potent adenosine receptor
antagonist, was added to the external solution, unless otherwise noted.
The standard internal solution ("intracellular" pipette solution
in whole-cell and outside-out configurations or bathing solution for
inside-out patches) containing (mmol/L) KCl 140, EGTA 5, HEPES 5, KOH
10, and MgCl2 1 (pH 7.2 adjusted with 1 mol/L KOH) was
supplemented by 0.1 mmol/L Na2ATP and 0.2 mmol/L
GTP lithium salt, unless otherwise noted. Other nucleotides and
different agents were added to either the external or the internal
solution according to the experimental protocol from stock solutions
just before use; the pH was carefully checked again after dilution of
nucleotides. The calculated free-Ca2+ concentration in the
internal solution was
0.1 nmol/L, and the estimated concentration of
free Mg2+ was kept constant at 1 mmol/L by adjusting
the concentration of MgCl2 for the Mg2+-binding
properties of nucleotides supplementing the solution.27
The pipette solution used in the perforated-patch configuration
contained (mmol/L) potassium aspartate 110, KCl 30, HEPES 10, and
MgSO4 2 (pH 7.2 adjusted with 1 mol/L KOH). Such a
composition was fitted to minimize Donnan's potential between this
solution and the cytoplasm. Amphotericin B (1 mg) dissolved in 8 µL
of DMSO was added to a small portion of the pipette solution to a final
antibiotic concentration of 200 µg/mL. The solution was sonicated,
light-protected, and stored at 4°C for no longer than 1 hour before
use. All aqueous and DMSO-based stock solutions were stored at
-20°C. DMSO, at a concentration 2-fold higher than that in any
external and internal solution, did not affect the whole-cell or the
single-channel current.
DPCPX (Research Biochemicals Inc), SQ-22536 (Biomol Research Laboratories, Inc), and PKI5-24 (GIBCO-BRL, Life Technologies) were used. Other compounds were obtained from Sigma.
Different bathing solutions, including the control one, were applied to a cell using an RSC-100 rapid solution changer system (Biologic) at a flow rate of 150 to 200 µL/min and a tube switching time of 200 milliseconds. Electrophysiological experiments were performed at 23°C to 24°C.
Whole-Cell and Single-Channel Current Recordings
Whole-cell current and single-channel current were recorded
using the patch-clamp technique.28 Micropipettes were
manufactured from borosilicate glass capillary tubes (GC120F-10, Clark
Electromedical Instruments) using a P-80/PC Flaming-Brown programmable
puller (Sutter Instrument Co). Pipettes with resistances of 1 to 2, 2
to 4, or 4 to 8 M
when filled with the pipette solution were used
for whole-cell current recordings in perforated-patch and conventional
whole-cell modes or for single-channel current recordings in
cell-attached and excised-patch configurations, respectively. The
liquid junction potential between standard external and internal
solutions was <2 mV and was not taken into account. The junction
potential between the standard external solution and the pipette
solution for perforated-patch recordings was
10 mV and was
subtracted from the command potential. Electrophysiological criteria
for the acceptance of a cell for an experiment were a membrane
potential more negative than -70 mV (estimated in zero current-clamp
mode) and a steady state outward current at -40-mV holding potential.
Whole-cell currents were recorded using an RK-400 cell/patch-clamp
amplifier (Biologic) at a holding potential of -40 mV and during
repetitive slow (0.05-mV/ms) voltage-ramp stimuli from +50 to -100 mV
(voltage from -40 to +50 mV and from -100 to -40 mV was changed at
the voltage-ramp rate of 1 mV/ms). This voltage protocol allowed for
essentially complete inactivation of Na+ current, and
Ca2+ current was also not detectable at 0 mV during the
ramp stimuli. Command potential generation as well as acquisition and
on-line analysis of currents elicited during voltage-clamp stimuli were
performed using a PCL-718 interface (Advantech Co) on a Pentium
computer and BioQuest software (WC2.6 version, developed by Dr A.
Alekseev, Mayo Clinic, Rochester, Minn). The whole-cell current was
continuously monitored on an NIC-310 digital oscilloscope (Nicolet
Instrument) and stored on magnetic tape using a DTR-1800 digital tape
recorder (Biologic) for later analysis. The currents recorded in
conventional whole-cell patch-clamp configuration were accepted at the
start of the 10th minute after membrane patch rupture if series
resistance, ranging from 8 to 16 MW, was quite stable (<10% increase
during the experiment). The currents recorded in perforated whole-cell
patch configuration were taken into account after 10 minutes of
achieving stable access resistance ranging from 8 to 16 MW. Series
resistances were compensated by 70% through the patch-clamp amplifier
circuit. Whole-cell currents were normalized to cell capacitance
(Cm), calculated as Cm=Q/V, where Q is the
charge estimated from the capacitative transient current recorded
during a hyperpolarizing 10-mV pulse (V) when micropipette capacitance
was compensated. Series resistance was calculated as
/Cm, where
was estimated from the best fit of the
capacitive transient current relaxation by exponential function. Leak
compensation was not applied.
Under the designed ionic conditions and voltage protocol, ATPe activates substantial inward currents through voltage-independent nonselective cationic20 and Cl- channels22 with reversal potential around 0 mV for both currents in the present ionic conditions. Thus, K+ current was estimated from the difference between currents recorded at 0 mV either during voltage-ramp stimuli applied at the time of interest or at the beginning of whole-cell current recording.
Single-channel currents were recorded using the integrator mode of the patch-clamp amplifier in cell-attached configuration at a holding potential of -70 mV in quasiphysiological ionic conditions (Na+-rich bathing and pipette solutions) or 0 mV with Na+-rich bathing and K+-rich pipette solutions and in excised-patch configurations at a holding potential of -40 mV in quasisymmetrical ionic conditions (K+-rich intracellular and extracellular solutions) or 0 mV in quasiphysiological ionic conditions (Na+-rich extracellular and K+-rich intracellular solution) at a five-pole Bessel filter cut-off frequency of 1 kHz and sampled at a step of digitization of 0.3 milliseconds on-line or during replay of records. Single-channel current-voltage relations were taken in the interactive mode using subtraction of the single-channel current traces recorded during the voltage-ramp stimuli applied when channels were predominantly in open or closed states. Single-channel currents were analyzed using BioQuest software (CHAN4.8 program). Slow fluctuations of the no-channel-open baseline current were removed by fitting of the baseline with a spline curve and subtraction of this fit from the signal. Quasisteady state channel activity was characterized by NPo. NPo was calculated by dividing the mean patch current estimated over a 30- to 60-second test interval by the mean unitary current amplitude. Mean current amplitudes were calculated from the difference between peaks in a multiple Gaussian fit to all-points current amplitude histograms constructed from corresponding 30- to 60-second current record segments. The NPo calculated over shorter (a few seconds) intervals was shown to fluctuate significantly. For presentation, long-time current records were digitized with a 6- or 60-millisecond step and plotted using SigmaPlot 5.0 software (Jandel Corp).
Data Analysis
Averaged values and error bars are expressed as mean±SD.
Statistical significance was evaluated by paired and unpaired
Student's t test, and differences with values of
P<.05 were considered to be significant. Fitting of
experimental data by theoretical functions was performed using a
nonlinear Marquardt-Levenberg curve-fit algorithm using SigmaPlot 5.0
or BioQuest software.
| Results |
|---|
|
|
|---|
ATPe Enhances IK-ATP Developing During Cell
Dialysis With a Low-ATP Solution
As described previously, depletion of ATPi by dialysis
of ventricular cardiomyocytes with ATP-free solution15 29
or treatment of cells voltage-clamped in the perforated-patch
configuration with oxidative phosphorylation and glycolysis blockers
(in our preliminary experiments) increased IK-ATP; the
increase soon gave way to rundown. However, dialyzing cells in the
conventional whole-cell patch configuration with a low ATP (100
µmol/L) and GTP (200 µmol/L)containing solution elicited a
slowly, quasilinearly increasing outward current that exhibited delayed
rundown. As shown in Fig 1A
, soon after breaking the
patch, only a negligible steady state current occurred at a holding
potential of -40 mV. Current traces recorded during voltage-ramp
stimuli (Fig 1
inset) demonstrated that the initial holding current was
predominantly due to IK1, which remained relatively
constant during at least 1 hour of recording in the presence of 10
µmol/L glibenclamide and was not significantly altered by
ATPe application (not shown, data from four cells). The
external application of 50 µmol/L ATP during the early period of
low-ATP cell dialysis induced only an inward current with an initial
large surge, as previously described.20 22 Within 15
minutes, the basal current started to become more outward; then,
ATPe triggered an outward current that developed on top of
the inward current and recovered on ATPe washout. ADP
negligibly increased the previously developed outward current, whereas
AMP and adenosine were not effective. The subsequent applications of
ATPe as well as of its poorly hydrolyzable analogue,
ATP
S, similarly modulated the outward current. The late application
of 10 µmol/L glibenclamide inhibited the current. As shown in
the inset, the current developing during ATPi depletion as
well as the current facilitated by the purinergic stimulation had a
reversal potential close to -85 mV, the equilibrium potential for
K+ in the given ionic conditions at 23°C; the latter
current demonstrated a quasiohmic current-voltage relation at
potentials positive to the reversal potential. Therefore, this
glibenclamide-sensitive current through K+ channels was
identified as IK-ATP. These results show that
ATPe in the presence of a P1-purinoceptor
antagonist mediates a substantial increase in IK-ATP only
when the current has already been partially activated during the
ATPi depletion. Thus, the modulatory effect of
ATPe may be defined as an enhancement of
IK-ATP.
|
A true steady state level of IK-ATP was not reached over 1
hour of whole-cell recordings under designed conditions of low-ATP
dialysis; instead, IK-ATP increased quasi-linearly.
Thus, the ATPe-induced changes in the rate of quasilinear
increase in IK-ATP; ie, the "slope" of
IK-ATP rather than the absolute values of the current were
analyzed. An algorithm of the IK-ATP slope calculation is
illustrated in Fig 1B
. First, IK-ATP was estimated from the
difference between currents recorded at 0 mV during voltage-ramp
stimuli applied either at the time of interest or at the beginning of
whole-cell current recording to eliminate contaminating steady state
IK1 and substantial ATPe-induced inward
currents. Second, the time course of IK-ATP at 0 mV was
constructed from a sequence of ramp current traces. Finally, the
ATPe-induced increase in slope of quasilinearly rising
IK-ATP (ie, "net slope") was estimated to
quantitatively characterize the ATPe-induced enhancement of
IK-ATP.
ATPe Enhances IK-ATP
Dose-Dependently
To establish a dose dependence of the purinergic-induced
enhancement of IK-ATP, each cell had to be evaluated with a
single application of ATP at a given concentration when a similar level
of the outward current (2 to 4 pA/pF at -40 mV) was reached to a
priori minimize cumulative phenomena, including desensitization, and
dependence of the ATPe-triggered effect on the previous
IK-ATP level (Fig 2
). As shown in the inset,
the best fit of experimental data was obtained by a pseudo-Hill
equation: I=Imax
[Cn(Cn+C50n)-1],
where I and Imax are the actual and maximal increases in
the quasilinear rise of IK-ATP, respectively; C and
C50 are the actual and half-maximal stimulatory
concentrations of ATPe, respectively; and n is the
pseudo-Hill coefficient, with C50=1.7 µmol/L, n=1,
and Imax=4.8 pA/pF per minute.
|
Purinoceptor-Induced Enhancement of IK-ATP Involves a
Gs Protein
In the absence of selective agonists and antagonists to
discriminate between the ionotropic P2X (transmitter-gated
cationic channels) and the P2Y (G proteincoupled)
purinoceptors, we first checked the involvement of any G protein in
mediating the IK-ATP enhancement by ATPe by
substituting 0.4 mmol/L GDPßS for 0.2 mmol/L GTP in the low
ATPcontaining pipette solution. As shown in Fig 3
,
this intervention substantially reduced the ATPe-induced
enhancement of IK-ATP (1.45±0.82 versus 4.86±1.35 pA/pF
per minute in control; P<.05 for paired and unpaired
t tests on four cell pairs from four heart dissociations).
To further check the type of G protein involved in mediating the effect
of ATPe, cells were preincubated for 6 to 7 hours at 37°C
with either 0.5 µg/mL PTX or 5 µg/mL CTX before the
electrophysiological experiments. Immobilization of Gi,o
proteins in the inactive state by PTX treatment did not affect the
purinergic enhancement of IK-ATP (5.06±3.10 versus
4.78±3.56 pA/pF per minute in myocytes similarly maintained during 5
to 8 hours but without PTX; P>.05 for paired and unpaired
t tests on five cell pairs from five heart dissociations).
On the other hand, the ATPe effect was strongly reduced in
CTX-treated cardio-myocytes (1.04±0.42 versus 4.49±1.81 pA/pF per
minute in cells similarly maintained but without CTX; P<.05
for paired t tests on five cell pairs from five different
heart dissociations). This inhibitory effect of CTX treatment was
attributed to specific immobilization of Gs proteins in the
GTP-bound state rather than to some nonspecific cell damage, because
Ca2+ current density was
3-fold higher than in
nontreated myocytes from the same batch (data not shown). These results
indicate that a Gs protein is involved in the signaling
mechanism mediating the ATPe-induced enhancement of
IK-ATP.
|
ATP-Induced Enhancement of IK-ATP Is Not Attributable
to a Membrane-Delimited GTP-Dependent Mechanism
To check the involvement of a membrane-delimited G
proteindependent signaling pathway mediating the enhancement of
IK-ATP, we examined the effect of GTPs applied to the
cytoplasmic side of inside-out patches bathed in low-ATP solution on
KATP channel activity when ATP as an extracellular ligand
was present at the outer side of the membrane. In preliminary
experiments on patches bathed in 100 µmol/L ATPcontaining
intracellular solution, without agonist in the pipette solution, it was
observed that values of NPo calculated over 30- to
60-second intervals might fluctuate spontaneously by up to 50% to
70%. The applications of 200 µmol/L GTP or 50 µmol/L
GTP
S were thus considered effective if they produced not less than a
2-fold increase in NPo. In experiments on 45 patches with
50 µmol/L ATP in the pipette solution, four different situations
were observed (Fig 4
): (1) In four so-called
"GTP
S+, GTP+" patches, both GTP and GTP
S triggered the
NPo increase (an observation that is usually attributed to
an agonist-dependent G proteininduced modulation of KATP
channel activity). (2) In 13 "GTP
S+, GTP-" patches, GTP was
not effective, whereas GTP
S increased the channel activity, which
indicates that in these membrane fragments, a G protein regulating the
channel was not linked to the receptor to ATPe. (3) In 13
"GTP
S-, GTP-" patches, neither GTP nor GTP
S stimulated
the channel activity, whereas removal of ATP from the intracellular
solution increased NPo to a value not less than 50% of the
initial one appearing immediately after the patch isolation in
nucleotide-free solution (a result interpreted as a lack of G
proteindependent modulation of otherwise operational channels). (4)
In 15 patches, NPo demonstrated a >50% decrease within
the first minute after the patch excision, or in the case of
ineffective application of both GTP and GTP
S, NPo
estimated over the first minute after removal of ATP from the bath was
<50% of the initial level; the situation was classified as channel
rundown (rundown patches). The probability of observations attributable
to a purinoceptor-induced G proteinmediated modulation of
KATP channel activity was low (13.3% of non-rundown
patches in which NPo was increased 8.05±3.99 times) (Fig 4B
). However, a rapid desensitization might have occurred during the
time of gigaseal formation in the presence of ATP in the pipette
(combined with loss of mechanism of recovery from desensitization upon
patch excision). In 12 experiments with a "two-layer"
ATP-containing pipette solution expected to minimize such a
desensitization phenomenon, GTP increased the channel activity in one
patch of 12; ie, there was a similar low probability (12.5%, 7.1-fold
increase in NPo). Moreover, in eight outside-out patches
with 100 µmol/L ATP and 200 µmol/L GTPcontaining
intracellular pipette solution, the addition of 50 µmol/L ATP to
the bath did not affect the channel activity (not shown). The increase
in KATP channel activity on applying GTP might be caused by
an agonist-independent GTP modulation of the channel as previously
shown for another G proteinregulated K+
channel.30 In another series of 37 patches without ATP in
the pipette solution, the application of GTP increased KATP
channel activity with a probability similar to that determined in the
presence of added ATPe (12.5%, 7.7±3.6-fold increase in
NPo). In a final series of experiments, we checked that the
increase in KATP channel activity in the absence of added
ATPe was not due to stimulation by ATP carried through the
patch membrane from the bath to the pipette solution. To prevent both
the appearance of ATP or an effect of adenosine, its hydrolysis
product, the pipette solution included apyrase (0.1 U/mL), DPCPX
(10 µmol/L), and glucose (5 mmol/L, to maintain
ectonucleotidase activity). The application of GTP and GTP
S was as
effective as in the previous experimental series (12.5%;
NPo was increased 6.90±3.25 times). Thus, the
ATPe-induced enhancement of IK-ATP did not
involve a direct G proteincoupling between purinoceptors and the
KATP channel.
|
ATP-Induced Enhancement of IK-ATP Is Dependent on
Adenylyl Cyclase Activity
Gs proteins, whose activation is required to mediate
the ATPe-induced enhancement of IK-ATP, are
known to be linked to adenylyl cyclase. To examine the involvement of
adenylyl cyclase in the signal pathway under these experimental
conditions, we tested the effects of 2'd3'-AMP and SQ-22536, two
structurally different adenylyl cyclase inhibitors, on the whole-cell
IK-ATP enhancement as well as on single KATP
channel currents in inside-out patches (Fig 5
). In
myocytes dialyzed with the low-ATP intracellular solution added with
either 200 µmol/L 2'd3'-AMP or 200 mmol/L SQ-22536 (in the
latter case after the cells had been preincubated with 200
µmol/L for 20 minutes at 37°C), ATPe-elicited
IK-ATP enhancement was significantly reduced (1.30±0.50
pA/pF per minute in five 2'd3'-AMPdialyzed cells versus 4.09±1.74
pA/pF per minute in five control cells from the same batch; 1.37±0.82
pA/pF per minute in four SQ-22536dialyzed myocytes versus 4.11±2.42
pA/pF per minute in four control cells from the same batch;
P<.05 by paired and unpaired t test). However,
at the same concentration, neither of the compounds affected
KATP channel activity or the single-channel current
amplitude in inside-out patches bathed in either nucleotide-free or
low-ATP and GTP-containing intracellular solution in the presence of
ATP at the outer side of membrane. Thus, the data suggest that adenylyl
cyclase activation plays an essential role in the
ATPe-induced enhancement of IK-ATP.
|
Additional experiments were performed to compare the
P2-purinoceptormediated enhancement with the one mediated
by isoproterenol (Fig 6
). Isoproterenol, applied at
1 µmol/L under the same experimental conditions, was more
effective than ATP (50 µmol/L) to enhance IK-ATP
(7.95±2.17 versus 4.49±1.81 pA/pF per minute; P<.05 by
unpaired t test). The ß-adrenoceptormediated
IK-ATP enhancement was comparable to the one reported in
cat ventricular cells.15 There was no significant additive
effect when the two agonists were applied simultaneously (8.75±3.23
pA/pF per minute in the presence of both 1 µmol/L isoproterenol
and 50 µmol/L ATPe versus 7.95±2.17 pA/pF per
minute in the presence of 1 µmol/L isoproterenol alone;
P>.05 by unpaired t test). Furthermore, in all
three groups, CTX similarly reduced the IK-ATP enhancement
(23.7±4.6%, 21.0±5.5%, and 24.6±5.8% in the presence of 50
µmol/L ATPe, 1 µmol/L isoproterenol, and both
50 µmol/L ATPe and 1 µmol/L isoproterenol,
respectively; P>.05 by unpaired t test).
|
PKA Does Not Mediate the ATPe-Induced Enhancement of
IK-ATP
The possibility that a subsequent PKA phosphorylation of the
KATP channel itself or some interacting channel regulatory
protein after cAMP production by adenylyl cyclase might be responsible
for IK-ATP enhancement was then examined (Fig 7
). Dialysis of cells with low ATPcontaining solution
supplemented with PKI5-24 (10 µmol/L) did not alter
the occurrence of IK-ATP. Furthermore, although
PKI5-24 administration prevented 10 µmol/L
forskolinelicited increase in Ca2+ current observed in
control cells from the same batch (when Ca2+ current was
measured in cells dialyzed with the low-ATPcontaining solution before
IK-ATP development and in cells dialyzed with the same
solution added with 5 mmol/L ATP; data not shown),
ATPe was similarly effective at enhancing
IK-ATP in five pairs of cells dialyzed with low-ATP pipette
solution with or without PKI5-24 (3.86±2.20 and 4.24±1.68
pA/pF per minute in PKI5-24-dialyzed and control cells,
respectively). The results demonstrate that PKA is not necessary for
mediating the IK-ATP enhancement by ATPe under
these experimental conditions, assuming that PKA inhibition was
achieved as was inferred from parallel experiments in which the
forskolin-induced increase in Ca2+ current was
prevented.
|
| Discussion |
|---|
|
|
|---|
These results were obtained using an experimental approach that allowed us to examine the agonist effect on currents through preactivated latent channels under conditions that preserved cell integrity. The whole-cell configuration of the patch-clamp technique was selected in most experiments to minimize disruption of native regulatory interaction of the KATP channel with the cytoskeleton31 or other neighboring proteins. Such a disorganization of natural membrane architecture might occur upon either isolation of membrane fragments to achieve excised-patch configurations32 or permeabilization of the sarcolemma to achieve an open-cell attached configuration.33 Under our experimental conditions, IK-ATP was activated during ATPi depletion in cells dialyzed with submillimolar (100 µmol/L) ATPcontaining glucose-free solution. This method was chosen because cell treatment with K+ channel openers or metabolic inhibitors activating KATP channels in intact cardiomyocytes is known to alter the channel sensitivity to nucleotides and sulfonylureas34 35 36 37 and because severe ATPi depletion during cell dialysis with ATP- and glucose-free solution induced a nonlinear increase in IK-ATP that rapidly gave way to rundown.38 The chosen ATPi concentration of 100 µmol/L was, on the one hand, low enough to induce a substantial IK-ATP, and, on the other hand, high enough to maintain KATP channels in an operational state. Moreover, at this submillimolar ATP concentration, KATP channel activity could be maximally increased after a rightward shift of the curve describing the Po-ATPi concentration relation, an effect attributed to the Gi,o protein that mediates the P1-purinoceptor stimulation.11 12
ATPe-Induced Enhancement of IK-ATP Implies
P2-Purinoceptor Stimulation Coupled to a Gs
ProteinDependent NonMembrane-Delimited Mechanism
Under the above experimental conditions, a slowly developing
current and the ATPe-enhanced current have all the
characteristics of IK-ATP, including voltage-independent
gating, reversal potential close to the equilibrium potential for
K+, pseudo-ohmic current-voltage relation, and inhibition
by glibenclamide. The dose-dependent enhancement of IK-ATP
elicited by ATPe shows a C50 of 1.7
µmol/L, a value in the same range as most of the previously reported
ATPe effects on the same cells.18 The
ATPe stimulatory effect is attributable to the activation
of a P2-purinergic G proteincoupled receptor (a member of
the seven transmembranespanning domain purinoceptor superfamily,
probably a P2Y subtype but not a P2X member of
the superfamily of ionotropic purinoceptors/transmitter-gated cationic
channels) since the effect (1) is observed in the presence of a
P1-purinoceptor antagonist when AMP and adenosine were
ineffective; (2) is mediated by various poorly hydrolyzable ATP
analogues, including those that do not activatethe nonselective
cationic current39 ; and (3) involves a G protein, since
the ATPe-induced enhancement of IK-ATP was
inhibited in the presence of GDPßS. The G protein was sensitive to
CTX but not to PTX, suggesting that a Gs rather than a
Gi,o protein mediates the ATPe effect. It has
already been proposed that stimulation of purinergic receptors in rat
ventricular cells implies a Gs protein to enhance
Ca2+ current.21 On the other hand, inward
rectifier K+ channels are known to be modulated by a
membrane-delimited mechanism that generally involves a PTX-sensitive G
protein; this has recently been extended to the
ATPe-induced modulation of the atrial muscarinic
channel.25 Our results do not support the contention that
ATPe increases activity of the KATP channel in
rat ventricular myocytes, a member of the same two
transmembranespanning domain K+ channel superfamily,
through such a direct mechanism. In the present work, GTP applied to
the cytoplasmic side of inside-out patches bathed in low-ATP solution
increases channel activity similarly in the absence and presence of
external ATP as well as under conditions excluding uncontrolled
stimulation of P2- or P1-purinoceptors. The
inhibitory effect of CTX treatment on the ATPe-induced
enhancement of IK-ATP is unlikely to be due to the cross
regulation of a Gi,o protein involving its phosphorylation
by PKA,40 since neither ADP ribosylation nor PKA
inhibition alters the ATPe effect. The previous
observations of an unchanged KATP channel activity when
applying a purified preactivated G
s subunit
to the intracellular side of inside-out patches from rat ventricular
cells8 are in line with a lack of direct Gs
protein control of KATP channel activity.
Activation of the Gs protein generally triggers
phosphorylation of various proteins by PKA as a consequence of adenylyl
cyclase activation and cAMP production. Both Kir 6.2 and SUR2, the
subunits reconstituting a cardiac-like KATP channel,
contain several consensus PKA phosphorylation sites.5 6 At
least one report involving canine myocytes described a cAMP-dependent
pathway to account for the ß-adrenergicinduced increase in
pinacidil-activated IK-ATP in the presence of high (5 to
10 mmol/L) ATPi.14 However, in cat
myocytes dialyzed with nucleotide-free solution, mimicking the
ß-adrenergic activation of adenylyl cyclase by adding
8-(4-chlorophenylthio)-cAMP did not induce IK-ATP
enhancement; similarly, the ß-adrenergic facilitation of
IK-ATP was not sensitive to PKA inhibition.15
The latter authors suggested that whatever their experimental
conditions, PKA could not be an important contributor to ß-adrenergic
stimulation of IK-ATP, since Ca2+ current was
not simultaneously increased by isoproterenol in myocytes internally
dialyzed with solutions containing low (
300 µmol/L) ATP even
in the presence of glucose. Under our experimental conditions,
dialyzing the cell with PKI5-24 did not prevent the
ATPe-induced enhancement of IK-ATP. Our results
indicate that PKA-dependent phosphorylation of the KATP
channel, if any, is not a limiting factor for its enhancement by
ATPe in these experiments. However, our results do not
exclude the possibility that under more physiological conditions,
PKA-dependent phosphorylation might alter KATP channel
properties.
Purinergic Stimulation of Adenylyl Cyclase Induces
IK-ATP Enhancement by Depleting Subsarcolemmal ATP
That CTX prevents the purinergic-induced enhancement of
IK-ATP suggests the involvement of adenylyl cyclase pathway
even though PKA-dependent phosphorylation is not mediating the effect.
A similar observation was made with the ß-adrenergicinduced
stimulation of IK-ATP in cat ventricular cells, since the
ß-adrenergic effect was shown to be prevented by cell dialysis with
solution supplemented by 2'd3'-AMP, an adenylyl cyclase
inhibitor.15 However, several recent reports demonstrate
direct inhibition of KATP channels by various
adenonucleotide derivatives (ADP-ribose41 and
diaden-osine polyphosphates42 ). The activation of this
cyclase to mediate the purinergic enhancement of IK-ATP was
supported by the observations that two adenylyl cyclase inhibitors,
2'd3'-AMP and SQ-22536, interacting respectively with the purine and
the catalytic site of the cyclase, strongly and to a similar level
reduce the ATPe-induced IK-ATP enhancement.
Moreover, we checked that both compounds, used at the same
concentration in both whole-cell and single-channel experiments, do not
directly alter the channel function in inside-out patches. Whether
ATPe enhances the cAMP level in cardiac cells is still
debatable. It is generally reported that ATPe does not
significantly affect the basal cAMP level but may increase or decrease
the ß-adrenergicmediated cAMP rise.21 43 44 However,
in a detailed study of rat ventricular cells taken in part from the
same dissociation batches as used in the present study, we found that
the extracellular application of ATP
S induces a significant 2-fold
increase in the cAMP level (M. Pucéat and G. Vassort, unpublished
data, 1996). Because of these observations and the fact that ATP is a
substrate of the adenylyl cyclase, it can be proposed that purinergic
stimulation by cyclase activation induces subsarcolemmal
ATPi depletion that will result in a relief of the
ATPi-dependent channel block and an increase in
IK-ATP. This proposal is supported by previous observations
that in the cell-attached configuration, KATP channels can
be activated in hypoxia without changes in the main intrinsic
properties as tested after excising the same membrane
patch.45 A similar relief of ATPi-dependent
inhibition of cardiac IK-ATP by localized ATPi
consumption has already been proposed after ß-adrenergic stimulation
in cat ventricular cells, a situation that more obviously implies
adenylyl cyclase activation.15 Under our experimental
conditions, ATPe was less effective than isoproterenol at
enhancing IK-ATP; the effects of both agonists were not
additive and were blocked by CTX. These observations indicate that a
common factor is involved, which among others could be a Gs
protein. However, it was recently proposed that adenylyl cyclase, the
component distal to receptor and Gs protein, limits
agonist-mediated increases in the effector system
activity.46 Since several adenylyl cyclase isoforms are
expressed in rat heart,47 we cannot distinguish whether
both agonists activate the same isoforms but to different extents or
whether isoproterenol activates the same isoforms as ATPe
as well as some others, which would account for its larger effect. A
relief of ATPi-dependent modulation of cardiac
IK-ATP also occurs with activation of the
Na+-K+ pump (Priebe et al38 ).
Priebe et al further demonstrated that the backward-running pump, being
then a nonphysiological source of ATPi, inhibits
KATP channels. It has been reported that glycolytically
generated ATP preferentially controls KATP
channels,48 and this has led to the idea that a
functionally compartmentalized ATPi (specifically a
subsarcolemmal pool with a lower ATP concentration that the cytosolic
bulk) controls channel activity. The above experiments were performed
in the absence of glucose; nevertheless, IK-ATP recovered
its basal level on ATPe removal. The subsarcolemmal ATP is
thus controlled by the cytosolic ATP content. There should not be a
significant diffusional barrier limiting access to the internal face of
the membrane, in agreement with effective modulation of
IK-ATP by switching on/off the
Na+-K+ pump,38 even though in the
latter work part of the effects could be attributed to ADP production
or removal, since ADP antagonizes ATPi inhibition of
KATP channel.49
Are Additional Mechanisms Involved in Mediating the
ATPe-Induced IK-ATP Enhancement?
In the above experiments involving CTX treatment as well as
2'd3'-AMP or SQ-22536 administration, the purinergic-induced
enhancement of IK-ATP could be inhibited to
30%. This
could be consequent to incomplete ADP ribosylation of the
Gs protein by CTX or to partial inhibition of the adenylyl
cyclase but to similar levels by the two types of compounds. Also
consider that ATPe has multiple effects,18 and
several of them might enhance IK-ATP despite our controlled
experimental conditions. Intracellular acidification is known to
increase this current.49 However, under bicarbonate-free
conditions and at room temperature, knowing the purinergic-induced
Cl-/HCO3- exchanger activation to
be characterized by a very high temperature-dependent
coefficient,26 we would expect this pathway to be strongly
limited. Purinergic stimulation is also expected to load the cell with
Na+ and Ca2+ ions after activation of the
nonselective cationic current and Ca2+ release by the
sarcoplasmic reticulum.18 Na+ influx might
activate the Na+-K+ pump and thus contribute to
ATPi depletion.38 However,
ATPe-induced inward cationic currents inactivate faster
than IK-ATP increases, and contribution of the pump should
be limited in our experiments by using a Na+-free internal
solution. Similarly, a 30% remaining enhancement of IK-ATP
was observed after inhibition of either Gs protein or the
adenylyl cyclasedependent step mediating the current enhancement by
isoproterenol,15 a stimulation not known to induce
Na+ influx but to induce
Cl--HCO3- exchanger activation
and acidosis.50 Ca2+i has long
been known to affect IK-ATP.51 Lately, a
Ca2+i-induced actin cytoskeleton disassembly
was shown to reduce KATP channel activity by facilitation
of channel rundown31 and to increase channel activity as a
result of a decrease in sensitivity to ATPi.52
Moreover, an involvement of sarcolemmal
Ca2+-ATPasedependent ATPi depletion could be
speculated. However, under our experimental conditions, the free
Ca2+ concentration in the pipette was buffered at
subnanomolar levels by 5 mmol/L EGTA. Furthermore, a similar
occurrence and ATPe-induced enhancement of
IK-ATP was observed in three cells dialyzed with 10
mmol/L BAPTA, a Ca2+ buffer with faster kinetics, which
should better prevent localized Ca2+
variations.53 Purinergic stimulation of cardiomyocytes is
also known to activate phospholipase C, which might not only produce
inositol trisphosphate but also activate PKC by diacylglycerol. Several
isoforms of this kinase, for which many consensus-phosphorylation sites
are present on Kir 6.2 and SUR2,5 6 are dependent on
Ca2+ ions, although it should be noted that
Ca2+-independent PKC isoforms are predominantly
translocated during purinergic stimulation of rat ventricular
myocytes.54 PKC
has already been suggested to mediate
the acetylcholine-induced stimulation of cardiac
IK-ATP.13 It is also reported that treatment
with phorbol 12-myristate 13-acetate increases IK-ATP
induced by pinacidil or metabolic inhibition in rabbit ventricular
cells, with the latter effect requiring concomitant adenosine receptor
activation.55 Furthermore, superfusion of rabbit and human
ventricular myocytes with phorbol 12,13-didecanoate favors activation
of IK-ATP in rabbit cells dialyzed with submillimolar
ATPcontaining solutions, probably by reducing the channel sensitivity
to ATPi.56 However, a mixture of purified
constitutively active isoforms of PKC (
, ß,
, and
) was
shown to reduce activity of KATP channels in the presence
of substantially lower (50 µmol/L) ATP at the inner side of
inside-out membrane fragments from rabbit ventricular
cells.57 Other, yet poorly investigated, mechanisms are
possible, namely, the purinergic-triggered tyrosine kinase activation
of phospholipase C
,58 which could contribute to
ATPe-induced IK-ATP modulation in particular,
since the phospholipase C substrate, phosphatidylinositol diphosphate,
also regulates actin cytoskeleton assembly. However, we can conclude
that at least in our experimental conditions, an adenylyl
cyclasedependent, but PKA-independent, signaling mechanism is the
predominant pathway for the purinergic-induced enhancement of
IK-ATP.
Physiopathological Implications
The naturally occurring stimulation of KATP channels
by ATPe could be of major physiopathological importance in
view of the reported effects of K+ channel
openers.59 Except at high concentrations, at which these
drugs may accelerate automaticity and promote reentry, most recent
studies have shown that K+ channel openers are effective in
suppressing polymorphic ventricular tachyarrhythmias induced by early
afterdepolarizations and triggered activity in vivo. During hypoxia and
ischemia, a concomitant increase in intracellular ADP and
acidosis will act to shift the apparent ATPi sensitivity of
the K+ channel.3 ATP that is released under
these conditions may exert a cardioprotective effect by augmenting the
already occurring cytoprotective action potential shortening in these
cells. Because of the large KATP channel conductance and
its high density, <1% of the channel population is sufficient to
account for the degree of action potential shortening seen during
hypoxia60 61 62 ; consequently, ATPe has potential
significant modulatory effects on action potential duration. A diverse
situation might happen in the neighboring healthy cells, since the
purinergic-induced enhancement would not occur at normal
ATPi levels. In these cells, a sudden ATPe rise
will not activate KATP channels but will depolarize the
cells and trigger abnormal automaticity. This will add to intrinsic
heterogeneity between epicardium and endocardium and be the basis of
arrhythmias. Furthermore, KATP channels may be involved in
the protective effect of ischemic preconditioning in relation
to their expected activation by adenosine. Since ATP is released in
ischemia, a role of P2-purinergic stimulation in
preconditioning can also be foreseen.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received August 23, 1996; accepted January 10, 1997.
| References |
|---|
|
|
|---|
2. Trautwein W, Gottstein U, Dudel J. Der Aktionstrom der Myokardfaser im Sauerstoffmangel. Pflugers Arch. 1954;260:40-60. [Medline] [Order article via Infotrieve]
3.
Nichols CG, Lederer WJ. Adenosine
triphosphate-sensitive potassium channels in the cardiovascular
system. Am J Physiol. 1991;261:H1675-H1686.
4.
Terzic A, Jahangir A, Kurachi Y. Cardiac
ATP-sensitive K+ channels: regulation by intracellular
nucleotides and K+ channel-opening drugs.
Am J Physiol. 1995;269:C525-C545.
5.
Inagaki N, Gonoi T, Clement JP IV, Namba N, Inazawa J,
Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J. Reconstitution of
IK(ATP): an inward rectifier subunit plus the sulfonylurea
receptor. Science. 1995;270:1166-1170.
6. Inagaki N, Gonoi T, Clement JP IV, Wang CZ, Aguilar-Bryan L, Bryan J, Seino S. A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron. 1996;16:1011-1017. [Medline] [Order article via Infotrieve]
7. Babenko AP, Samoilov VO, Kazantseva ST, Shevchenko YL. ATP-sensitive K+-channels in the human adult ventricular cardiomyocyte membrane. FEBS Lett. 1992;313:148-150. [Medline] [Order article via Infotrieve]
8.
Kirsch GE, Codina J, Birnbaumer L, Brown AM.
Coupling of ATP-sensitive K+ channels to A1
receptors by G proteins in rat ventricular myocytes.
Am J Physiol. 1990;259:H820-H826.
9.
Ito H, Tung RT, Sugimoto T, Kobayashi I, Takahashi K,
Katada T, Ui M, Kurachi Y. On the mechanism of G protein ß
subunit activation of the muscarinic K+ channel in guinea
pig atrial cell membrane: comparison with the ATP-sensitive
K+ channel. J Gen Physiol. 1992;99:961-983.
10. Kurachi Y, Tung RT, Ito H, Nakajima T. G protein activation of cardiac muscarinic K+ channels. Prog Neurobiol. 1992;39:229-246. [Medline] [Order article via Infotrieve]
11. Terzic A, Tung RT, Inanobe A, Katada T, Kurachi Y. G proteins activate ATP-sensitive K+ channels by antagonizing ATP-dependent gating. Neuron. 1994;12:885-893. [Medline] [Order article via Infotrieve]
12.
Ito H, Vereecke J, Carmeliet E. Mode of
regulation by G protein of the ATP-sensitive K+ channel in
guinea pig ventricular cell membrane. J Physiol
(Lond). 1994;478:101-108.
13.
Wang YG, Lipsius SL. ß-Adrenergic stimulation
induces acetylcholine to activate ATP-sensitive K+ current
in cat atrial myocytes. Circ Res. 1995;77:565-574.
14. Tseng GN, Hoffman BF. Actions of pinacidil on membrane currents in canine ventricular myocytes and their modulation by intracellular ATP and cAMP. Pflugers Arch. 1990;415:414-424. [Medline] [Order article via Infotrieve]
15.
Schackow TE, Ten Eick RE. Enhancement of
ATP-sensitive potassium current in cat ventricular myocytes by
ß-adrenoreceptor stimulation. J Physiol
(Lond). 1994;474:131-14.
16. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J. 1986;233:309-319. [Medline] [Order article via Infotrieve]
17. Vial C, Owen P, Opic II, Posel D. Significance of release of adenosine triphosphate and adenosine induced by hypoxia or adrenaline in perfused rat heart. J Mol Cell Cardiol. 1987;19:187-197. [Medline] [Order article via Infotrieve]
18. Vassort G, Pucéat M, Scamps F. Modulation of myocardial activity by extracellular ATP. Trends Cardiovasc Med. 1994;4:236-240.
19.
Friel DD, Bean BP. Two ATP-activated
conductances in bullfrog atrial cells. J Gen
Physiol. 1988;91:1-27.
20. Scamps F, Vassort G. Mechanism of extracellular ATP-induced depolarization in rat isolated ventricular cardiomyocytes. Pflugers Arch. 1990;417:309-316. [Medline] [Order article via Infotrieve]
21.
Scamps F, Rubin V, Pucéat M, Tkachuk V, Vassort
G. A Gs couples P2-purinergic
stimulation to cardiac Ca channels without cyclic AMP
production. J Gen Physiol. 1992;100:675-701.
22. Kaneda M, Fukui K, Doi K. Activation of chloride current by P2-purinoceptors in rat ventricular myocytes. Br J Pharmacol. 1994;111:1355-1360. [Medline] [Order article via Infotrieve]
23. Friel DD, Bean BP. Dual control by ATP and acetylcholine of inwardly rectifying K+ channels in bovine atrial cells. Pflugers Arch. 1990;415:651-657. [Medline] [Order article via Infotrieve]
24.
Fu C, Pleumsamran A, Oh U, Kim D. Different
properties of the atrial G protein-gated K+ channels
activated by extracellular ATP and adenosine. Am J
Physiol. 1995;269:H1349-H1358.
25.
Matsuura H, Sakaguchi M, Tsuruhara Y, Ehara T.
Activation of the muscarinic K+ channel by
P2-purinoceptors via pertussis toxin-sensitive G proteins
in guinea-pig atrial cells. J Physiol (Lond). 1996;490:659-671.
26.
Pucéat M, Clément O, Vassort G.
Extracellular MgATP activates the
Cl-/CHO3--exchanger
in single rat
cardiac cells. J Physiol (Lond). 1991;444:241-256.
27. Fabiato A. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol. 1988;157:378-417. [Medline] [Order article via Infotrieve]
28. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981;391:85-100. [Medline] [Order article via Infotrieve]
29.
Noma A, Shibasaki T. Membrane current through
adenosine-triphosphate-regulated potassium channels in guinea-pig
ventricular cells. J Physiol (Lond). 1985;363:463-480.
30.
Okabe K, Yatani A, Brown AM. The nature and
origin of spontaneous noise in G protein-gated ion channels.
J Gen Physiol. 1991;97:1279-1294.
31. Furukawa T, Yamane TI, Terai T, Katayama Y, Hiraoka L. Functional linkage of the cardiac ATP-sensitive K+ channel to the actin cytoskeleton. Pflugers Arch. 1996;431:504-512. [Medline] [Order article via Infotrieve]
32. Trube G, Hescheler J. Inward-rectifying channels in isolated patches of the heart cell membrane: ATP-dependence and comparison with cell-attached patches. Pflugers Arch. 1984;401:178-184. [Medline] [Order article via Infotrieve]
33.
Kakei M, Noma A, Shibasaki T. Properties of
adenosine-triphosphate-regulated potassium channels in guinea-pig
ventricular cells. J Physiol (Lond). 1985;363:441-462.
34. Thuringer D, Escande D. Apparent competition between ATP and the potassium channel opener RP 49356 on ATP-sensitive K+ channels of cardiac myocytes. Mol Pharmacol. 1989;36:897-902. [Abstract]
35.
Nakayama K, Fan Z, Marumo F, Hiraoka M.
Interrelation between pinacidil and intracellular ATP concentrations on
activation of the ATP-sensitive K+ current in guinea pig
ventricular myocytes. Circulation. 1990;82:2044-2051.
36.
Deutsch N, Weiss JN. ATP-sensitive
K+ channel modification by metabolic inhibition in isolated
guinea-pig ventricular myocytes. J Physiol
(Lond). 1993;465:163-179.
37. Krause E, Englert H, Gögelein H. Adenosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicited by the channel opener rilmacalim. Pflugers Arch. 1995;429:625-635. [Medline] [Order article via Infotrieve]
38.
Priebe L, Friedrich M, Benndorf K. Functional
interaction between KATP channels and the
Na+-K+ pump in metabolically inhibited heart
cells of the guinea-pig. J Physiol (Lond). 1996;492:405-417.
39. Babenko AP, Vassort G. P2-purinoceptors-mediated enhancement of cardiac ATP-sensitive K+ channel (KATP) current. Prog Biophys Mol Biol. 1996;65:89. Abstract.
40. Levistre R, Berguerand M, Bereziat G, Masliah J. The cross-regulation of Gi-protein by cholera toxin involves a phosphorylation by protein kinase A. Biochem J. 1995;306:765-769.
41. Kwak YG, Park SK, Kim UH, Han MK, Eun JS, Cho KP, Chae SW. Intracellular ADP-ribose inhibits ATP-sensitive K+ channels in rat ventricular myocytes. Am J Physiol. 1996;40:C464-C468.
42. Jovanovic A, Terzic A. Diadenosine tetraphosphate-induced inhibition of ATP-sensitive K+ channels in patches excised from ventricular myocytes. Br J Pharmacol. 1996;117:233-235. [Medline] [Order article via Infotrieve]
43.
Zheng JS, Christie A, DeYoung MB, Levy MN, Scarpa
A. Synergism between cAMP and ATP in signal transduction in
cardiac myocytes. Am J Physiol. 1992;262:C128-C135.
44.
Yamada M, Hamamori Y, Akita H, Yokoyama M.
P2-purinoceptor activation stimulates phosphoinositide
hydrolysis and inhibits accumulation of cAMP in cultured ventricular
myocytes. Circ Res. 1992;70:477-485.
45. Babenko AP, Samoilov VO, Kazantseva ST. Potassium channels in the cardiomyocyte sarcolemma: initial opening under influence of hypoxia. Basic Appl Myol. 1992;2:317-324.
46. Post SR, Hilal-Dandan R, Urasawa K, Brunton LL, Insel PA. Quantification of signalling components and amplification in the ß-adrenergic-receptor-adenylate cyclase pathway in isolated adult rat ventricular myocytes. Biochem J. 1995;311:75-80.
47. Espinasse I, Iourgenko V, Defer N, Samson F, Hanoune J, Mercadier JJ. Type V, but not type VI, adenylyl cyclase mRNA accumulates in the rat heart during ontogenetic development: correlation with increased global adenylyl cyclase activity. J Mol Cell Cardiol. 1995;27:1789-1795. [Medline] [Order article via Infotrieve]
48.
Weiss JN, Lamp ST. Glycolysis preferentially
inhibits ATP-sensitive K+ channels in isolated guinea pig
myocytes. Science. 1987;238:67-69.
49.
Lederer WJ, Nichols CG. Nucleotide modulation of
the activity of rat heart ATP-sensitive K+ channels in
isolated membrane patches. J Physiol (Lond). 1989;419:193-211.
50.
Désilets M, Pucéat M, Vassort G.
Chloride dependence of pH modulation by ß-adrenergic agonist in rat
cardiomyocytes. Circ Res. 1994;75:862-869.
51. Findlay I. ATP-sensitive K channels in rat ventricular myocytes are blocked and inactivated by internal divalent cations. Pflugers Arch. 1987;410:313-320. [Medline] [Order article via Infotrieve]
52.
Terzic A, Kurachi Y. Actin microfilament
disrupters enhance KATP channel opening in patches from
guinea-pig cardiomyocytes. J Physiol (Lond). 1996;492:395-404.
53.
Marty A, Neher E. Potassium channels in cultured
bovine adrenal chromaffin cells. J Physiol
(Lond). 1985;367:117-141.
54. Pucéat M, Vassort G. Signalling by protein kinase C isoforms in the heart. Mol Cell Biochem. 1996;157:65-72. [Medline] [Order article via Infotrieve]
55.
Liu Y, Gao WD, O'Rourke B, Marban E.
Synergistic modulation of ATP-sensitive K+ currents by
protein kinase C and adenosine: implications for ischemic
preconditioning. Circ Res. 1996;78:443-454.
56.
Hu K, Duan D, Li G-R, Nattel S. Protein kinase C
activates ATP-sensitive K+ current in human and rabbit
ventricular myocytes. Circ Res. 1996;78:492-498.
57. Light PE, Allen BG, Walsh MP, French RJ. Regulation of adenosine triphosphate-sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphatase. Biochemistry. 1995;34:7252-7257. [Medline] [Order article via Infotrieve]
58.
Pucéat M, Vassort G. Purinergic
stimulation of rat cardiomyocytes induces tyrosine phosphorylation and
membrane association of phospholipase C
: a major mechanism for
InsP3 generation. Biochem J. 1996;318:723-728.
59. Escande D, Cavero I. Potassium channel openers in the heart. In: Escande D, Standen N, eds. K+ Channels in Cardiovascular Medicine. Paris, France: Springer-Verlag; 1993:225-244.
60.
Findlay I, Deroubaix E, Guiraudou P, Coraboeuf
E. Effects of activation of ATP-sensitive K+
channels in mammalian ventricular myocytes. Am J
Physiol. 1989;257:H1551-H1559.
61.
Nichols CG, Lederer WJ. The regulation of
ATP-sensitive K+ channel activity in intact and
permeabilized rat ventricular myocytes. J Physiol
(Lond). 1990;423:91-110.
62.
Nichols CG, Ripoll C, Lederer WJ. ATP-sensitive
potassium channel modulation of the guinea pig ventricular action
potential and contraction. Circ Res. 1991;68:280-287.
This article has been cited by other articles:
![]() |
R. Fischmeister, L. R.V. Castro, A. Abi-Gerges, F. Rochais, J. Jurevicius, J. Leroy, and G. Vandecasteele Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of Cyclic Nucleotide Phosphodiesterases Circ. Res., October 13, 2006; 99(8): 816 - 828. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinmura, K. Tamaki, T. Sato, H. Ishida, and R. Bolli Prostacyclin attenuates oxidative damage of myocytes by opening mitochondrial ATP-sensitive K+ channels via the EP3 receptor Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2093 - H2101. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Xiao, A. Hara, K.-i. Yuhki, T. Fujino, H. Ma, Y. Okada, O. Takahata, T. Yamada, T. Murata, S. Narumiya, et al. Roles of Prostaglandin I2 and Thromboxane A2 in Cardiac Ischemia-Reperfusion Injury: A Study Using Mice Lacking Their Respective Receptors Circulation, October 30, 2001; 104(18): 2210 - 2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vassort Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium Physiol Rev, April 1, 2001; 81(2): 767 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishiyama, D. S. A. Majid, K. A. Taher, A. Miyatake, and L. G. Navar Relation Between Renal Interstitial ATP Concentrations and Autoregulation-Mediated Changes in Renal Vascular Resistance Circ. Res., March 31, 2000; 86(6): 656 - 662. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Gomez, B. G. Kerfant, and G. Vassort Microtubule Disruption Modulates Ca2+ Signaling in Rat Cardiac Myocytes Circ. Res., January 7, 2000; 86(1): 30 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Babenko, G. Gonzalez, L. Aguilar-Bryan, and J. Bryan Reconstituted Human Cardiac KATP Channels : Functional Identity With the Native Channels From the Sarcolemma of Human Ventricular Cells Circ. Res., November 30, 1998; 83(11): 1132 - 1143. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Babenko and J. Bryan A Conserved Inhibitory and Differential Stimulatory Action of Nucleotides on KIR6.0/SUR Complexes Is Essential for Excitation-Metabolism Coupling by KATP Channels J. Biol. Chem., December 21, 2001; 276(52): 49083 - 49092. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |